4.1 Article

Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in Trypanosoma cruzi

期刊

STAR PROTOCOLS
卷 3, 期 2, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.xpro.2022.101324

关键词

-

资金

  1. INOVA Fiocruz [VPPCB-007-FIO-18-2-37]
  2. European Union [602080]
  3. Conselho Nacional de Pesquisa (CNPq)
  4. Research Foundation from the State of Parana (Fundacao Araucaria)
  5. INOVA Research Program from FIOCRUZ
  6. Centre National de la Recherche Scientifique (CNRS)
  7. Institut National de la Santeet de la Recherche Medicale (INSERM)
  8. Universitede Strasbourg

向作者/读者索取更多资源

This study presents a novel genetic complementation strategy for investigating gene function in Trypanosoma cruzi, the parasite responsible for Chagas disease. By combining CRISPR-Cas9 technology with recombination of resistant variants of the target gene containing desired mutations, detailed exploration of protein function is made possible. This experimental approach overcomes some of the limitations associated with traditional gene knockouts in T. cruzi.
This protocol outlines a new genetic complementation strategy to investigate gene function in Trypanosoma cruzi, the parasite causing Chagas disease. We combine CRISPR-Cas9 technology with recombination of variants of the target gene containing the desired mutations that are resistant to Cas9-cleavage, which enables detailed investigation of protein function. This experimental strategy overcomes some of the limitations associated with gene knockouts in T. cruzi. For complete details on the use and execution of this protocol, please refer to Marek et al. (2021).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据